Table indicating whether a risk factor showed a significant association with complicated grief for any time point in the study. by Emma A. M. Sanderson (12225310)

DHA decreased cell viability in HepG3 cells. by Arlet Hernandez (12289155)

Pathway associated with decreased inflammation. by Monica N. Mweetwa (17054522)

Cell growth and viability decrease confirmed by growth inhibition in HepG3. by Arlet Hernandez (12289155)

Interrupted time series analysis for self-protective behaviors using significant variation in COVID-19 cases as the intervention date (dashed horizontal line). by Javier Alvarez-Galvez (454797)

Overview of measures across the three time points. by Irina Jarvers (10704223)

Subjects:

The number of significantly downregulated and upregulated differentially expressed genes for all 8 analyses with an p-adjusted value of 0.05. by Michael R. van Gerven (16764526)

HFD decreases intermediate-term memory. by Tong Yue (6033305)

“…<p>(A) The survival rate of 10d <i>Canton-S</i> fed with ND or HFD was observed for 7 days. There was no significant decline in the survival rate in flies fed with HFD compared with ND (n = 10 vials, containing 20 flies at each time point). …”

AMS scores decrease over three days at high-altitude. by Erica C. Heinrich (6832055)

Pro- and anti-inflammatory cytokines are significantly decreased at acute time points following IR. by Jordan A. Gunning (18143970)

Parasite burden is significantly decreased in the small intestine of <i>taiep</i> infected rats. by Karen Elizabeth Nava-Castro (6940340)

Response of small airway tissues infected with EV-D94 and decreasing doses of EV-D68. by Ines Cordeiro Filipe (5849144)

“…<p>Tissues were infected with 1E7 RNA copies of EV-D94 (equivalent to 2,46E4 TCID50) and 1E7 RNA copies of EV-D68 (3,3E5 TCID50) as well as decreasing doses of the latter. A and B: Viral loads were quantified by RT-PCR from apical wash samples collected at the indicated time points (A) or from tissues lysed at 2dpi (B). …”

Scatter plot for the significant Mendelian randomization (MR) association (P < 0.05) between mediators and anti-H. pylori IgG seropositivity. by Jing Wang (6206297)

Subjects:

Distribution of willingness to risk exposure by COVID-negative status. by Fabrice Etilé (4741332)

Subjects:

Patient demographic information at four time points. by Ruitian Song (11045127)

Subjects:

Summary of post-treatment disease course measures from MDMA-AT publications. by Filip Stanicic (17808254)

Subjects:

Study selection criteria. by Filip Stanicic (17808254)

Subjects:

Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications. by Filip Stanicic (17808254)

Subjects:

Disease course measures after the PTSD treatments. by Filip Stanicic (17808254)

Subjects:

PICOS criteria for the SLR. by Filip Stanicic (17808254)

Subjects: